Company / Cash & Equivalents
Microbot Medical Inc. Cash & Equivalents History
FY2011-FY2015 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Cash & Equivalents
$30.6M
FY2015
5-year range
$8.5M / $38.6M
FY2011-FY2015
Trend
+261.0%
vs FY2014
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Cash & Equivalents changed +261% YoY in FY2015, a notable deviation from the 4-year average annual change of +36%.
Based on SEC 10-K filings.
$31M in FY2015 with a 3-year CAGR of +15.8%.
Improved from $13M to $31M over the past 2 years.
Cash & Equivalents over time
Growth rates
- 3-Year CAGR
- +15.8%
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Key checks
Key Insights
- 3-year CAGR of +15.8%, indicating consistent growth.
- In FY2015, cash & equivalents increased 261.0% year-over-year.
- Peak cash & equivalents was recorded in FY2011.
- Lowest cash & equivalents in the period was in FY2014.
Company context
Key Data Points
- Altman Z-Score -2.00 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Cash & EquivalentsValue | YoY GrowthYoY |
|---|---|---|
| FY2015 | $30.6M | +261.0% |
| FY2014 | $8.5M | -36.4% |
| FY2013 | $13.3M | -32.5% |
| FY2012 | $19.7M | -49.0% |
| FY2011 | $38.6M | - |
As of FY2015 · SEC 10-K · Updated Jun 24, 2026